Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)December 12, 2006
CytoCore, Inc.
Delaware | 0-935 | 36-4296006 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
414 North Orleans Street, Suite 502, Chicago, Illinois | 60610 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code(312) 222-9550
N/A
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 8.01 Other Events | ||||||||
Item 9.01 Financial Statements and Exhibits. | ||||||||
SIGNATURES | ||||||||
Press Release |
Table of Contents
Item 8.01 Other Events
On December 12, 2006, CytoCore, Inc. announced that it had tendered payment of principal and accrued interest to a note holder, the Company’s largest creditor. This payment will reduce the Company’s liabilities by approximately $1.7 million.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. | Description | |
99.1 | Press release dated December 12, 2006 |
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CytoCore, Inc. | ||||
Dated: December 13, 2006 | By: | /s/ Robert F. McCullough | ||
Robert F. McCullough | ||||
Chief Financial Officer | ||||